Physicochemical and Biological Characterization of the Proposed Biosimilar Tocilizumab

Figure 6

Charge heterogeneity comparison of HS628 and originator tocilizumab. (a) CEX chromatograms of HS628 and originator tocilizumab, (b) CEX chromatograms of HS628 and originator tocilizumab after CPB digest, and (c) cIEF chromatograms of HS628 and originator tocilizumab.

(a)

(b)

(c)